Ellevest Inc’s Definitive Healthcare DH Stock Holding History

Ellevest Inc’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-286	Closed	-$2.95K	–	675
2023 Q1	$2.95K	Buy	286 +240	+522%	+$2.83K	﹤0.01%	1358
2022 Q4	$506	Buy	+46	New	+$591	﹤0.01%	1615

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ellevest Inc's DH Position: Q2 2023 in Review

Ellevest Inc sold out of Definitive Healthcare (DH) in Q2 2023, closing a stake of 286 shares — an estimated $2.95K sold.

Ellevest Inc first reported a position in DH in Q4 2022 and held it in 2 quarters. The position peaked at $2.95K in Q1 2023. 137 funds tracked by Wall St. Rank hold DH as of Q2 2023.

Ellevest Inc reported no remaining Definitive Healthcare position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 286 Definitive Healthcare shares in Q2 2023, an estimated $2.95K.
Ellevest Inc first reported a position in Definitive Healthcare in Q4 2022 and held it in 2 quarters.
Ellevest Inc's Definitive Healthcare position peaked at $2.95K in Q1 2023.
137 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.